Abstract

Children’s cancer is par excellence a disease of a multidisciplinary nature. It is therefore unrealistic to expect a single person with a single qualification to have the skills and capabilities to carry out a comprehensive assessment and institute competent interventions in all these areas. Decisions and interventions will be in accordance with the decision of the multidisciplinary committee of therapeutic indications.According to the WHO, every year approximately 400,000 children and adolescents between the ages of 0 and 19 develop cancer. The most common childhood cancers include leukemias, brain cancers, lymphomas, and solid tumors such as neuroblastoma and Wilms tumors [1, 2, 3]. In 2019 globally there were 291.3 thousand new cases and 98.8 thousand deaths from childhood cancer worldwide, with a prevalence of 1.8 million [4]. However, the 5-year survival of childhood cancer patients has increased impressively to more than 80% in recent decades, mainly attributed to improved diagnostic technologies and multiagent cytotoxic regimens.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.